Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications
A Phase 1 Study of Convection-Enhanced Delivery of Intraputaminal AAV2-GDNF in Advanced Parkinson's Disease.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: April 07, 2026
Persistent GDNF Expression 45 Months after Putaminal Infusion of AAV2-GDNF in a Patient with Parkinson's Disease.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: March 26, 2024
Objective response to ethanol in essential tremor: results from a standardized ethanol challenge study.
Journal: Annals of clinical and translational neurology
Published: October 04, 2023
Long-term safety of MRI-guided administration of AAV2-GDNF and gadoteridol in the putamen of individuals with Parkinson's disease.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: April 25, 2023
Comparison of Ultrasound and Electrical Stimulation Guidance for Onabotulinum Toxin-A Injections: A Randomized Crossover Study.
Journal: Movement disorders clinical practice
Published: March 19, 2022
Enrollment of Participants From Marginalized Racial and Ethnic Groups: A Comparative Assessment of the STEADY-PD III and SURE-PD3 Trials.
Journal: Neurology. Clinical practice
Published: March 17, 2022
Long-term safety of MRI-guided administration of AAV2-GDNF and gadoteridol in the putamen of individuals with Parkinson's disease.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: February 16, 2022
Where Do Parkinson's Disease Patients Look While Walking?
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: September 08, 2021
Last Updated: 09/26/2026